unmodified allogeneic gamma delta T cell therapy (TCB007) / TC Biopharm - LARVOL DELTA

Scotland testing COVID-19 therapy to boost immune response early in the infection (The Week UK) - "TC BioPharm, a Scottish biotech firm, has won approval to test an experimental T-cell injection therapy to fight COVID-19 by boosting the immune system early in a coronavirus infection....The six-month trial in Edinburgh will involve harvesting T-cells from healthy people, cultivating a large number of the cells in a lab, then injecting the donor cells into hospitalized patients....Trial will focus on gamma delta T-cells, the 'bully boys' of the immune system. 'T-cells decrease in number as people get older, so the injections might be especially helpful for elderly patients.'"

Cytokine storm • New trial • Infectious Disease • Novel Coronavirus Disease